Showing results (191-200 of 201) with videos related to
Sort By:
Pageof 21
Oncotarget|June 19, 2014
Acrolein- and 4-Aminobiphenyl-DNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cellsHyun-Wook Lee, Hsiang-Tsui Wang, Mao-wen Weng, et al.Oncotarget|March 26, 2016
Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 proteinJuliana F Ortega, Aline de Conti, Volodymyr Tryndyak, et al.International Journal of Cancer|December 5, 2013
Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesisAline H Guariento, Kelly S Furtado, Aline de Conti, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 19, 2020
Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse modelAline de Conti, Volodymyr Tryndyak, Rose A Willett, et al.Mutagenesis|October 24, 2013
Mechanistic insights into the cytotoxicity and genotoxicity induced by glycidamide in human mammary cellsSusana Bandarra, Ana S Fernandes, Inês Magro, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 14, 2023
Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitroAlec T Salminen, Kelly J Davis, Robert P Felton, et al.Genome Research|March 9, 2019
Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humansMaria Zhivagui, Alvin W T Ng, Maude Ardin, et al.Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.Journal of the National Cancer Institute|September 10, 2019
The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard IdentificationJonathan M Samet, Weihsueh A Chiu, Vincent Cogliano, et al.Pageof 21